Daniel Eriksson
Berlin, BE 13342, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Report of high data rate macromolecular crystallography (HDRMX) meeting, 23 July 2025.
Journal: Structural dynamics (Melville, N.Y.)
Published: October 11, 2025
Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.
Journal: Cardiology research and practice
Published: September 06, 2019
Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: August 09, 2019
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.
Journal: European heart journal. Quality of care & clinical outcomes
Published: July 11, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: July 01, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 10, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Journal: The American journal of medicine
Published: March 31, 2019
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Journal: Pharmacotherapy
Published: January 01, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: June 03, 2018
Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: April 10, 2018
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 21, 2017
Last Updated: 09/26/2026